Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
ABBOTT LABORATORIES
ABT
Healthcare
Medical Devices
Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the...
international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NYSE:ABT)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 02, 2022 12:01am
New Press Release - ABBOTT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Abbott Laboratories and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Abbott Laboratories (“Abbott” or the “Company”) (NYSE: ABT) in the United States District Court for the Northern District of Illinois on behalf of all...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 01, 2022 5:44pm
New Press Release - Abbott Laboratories Deadline Alert
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Abbott Laboratories To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - September 1, 2022) - Faruqi & Faruqi, LLP, a leading national securities law...
read article.
Xcyte Digital Corp. Releases "Xperience" Subscription Service
posted May 17, 2024 9:00am by
Xcyte Digital Corp.
-
|
"Xcyte anticipates growing the Xperience one-stop offering further with additional event technologies and supporting services, such as digital marketing and lead generation. We look forward to providing future updates as we execute upon this growth strategy ...read more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 01, 2022 4:12pm
New Press Release - EQUITY ALERT: Rosen Law Firm Encourages Abbott Laboratories Investors to Inquire About Class Action Investigation - ABT
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Abbott Laboratories (NYSE: ABT) resulting from allegations that Abbott may have issued materially misleading business information to the investing public....
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 01, 2022 12:35pm
New Press Release - INVESTOR DEADLINE: Abbott Laboratories Investors with Substantial Losses Have Opportunity to Lead the Abbott Laboratories Class Action Lawsuit - ABT
San Diego, California--(Newsfile Corp. - September 1, 2022) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Abbott Laboratories (NYSE: ABT) common stock between February 19, 2021 to June 8, 2022, inclusive (the "Class Period") have until October 31...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 01, 2022 12:30pm
New Press Release - INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Abbott Laboratories with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / September 1, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Abbott Laboratories ("Abbott" or "the Company") (NYSE:ABT) for violations of §§10(b) and 20(a) of the Securities Exchange Act...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 01, 2022 8:50am
New Press Release - SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Abbott Laboratories with Losses of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Abbott Laboratories (“Abbott” or “the Company”) (NYSE: ABT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 31, 2022 8:32pm
New Press Release - INVESTOR ALERT: Abbott Laboratories Investors with Substantial Losses Have Opportunity to Lead the Abbott Laboratories Class Action Lawsuit - ABT
Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Abbott Laboratories (NYSE: ABT) common stock between February 19, 2021 to June 8, 2022, inclusive (the “Class Period”) have until October 31, 2022 to seek appointment as lead plaintiff in Pembroke Pines Firefighters...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 31, 2022 8:09pm
New Press Release - SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Abbott Laboratories with Losses of $100,000 to Contact the Firm
LOS ANGELES CA / ACCESSWIRE / August 31, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Abbott Laboratories ("Abbott" or "the Company") (NYSE:ABT) for violations of 10(b) and 20(a) of the Securities Exchange Act of...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 31, 2022 5:56pm
New Press Release - SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Abbott Laboratories with Losses of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Abbott Laboratories (“Abbott” or “the Company”) (NYSE: ABT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 31, 2022 5:39pm
New Press Release - Abbott Laboratories Deadline Alert
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Abbott Laboratories To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - August 31, 2022) - Faruqi & Faruqi, LLP, a leading national securities law...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 29, 2022 9:01am
New Press Release - New Data Show Abbott's HeartMate 3(TM) Heart Pump Extends Life Beyond Five Years for Advanced Heart Failure Patients
New data from the MOMENTUM 3 study showed for the first time that a heart pump can extend survival to five years and beyond for advanced heart failure patientsPrior data1 have shown survival for advanced heart failure patients who don't receive either a heart pump or heart transplant is less than...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 23, 2022 9:00am
New Press Release - FDA Approves Abbott's New Spinal Cord Stimulation Device; Provides Tailored Relief to Multiple Pain Areas and Adds More Treatment Options for Evolving Pain Conditions
Abbott's new Proclaim™ Plus spinal cord stimulation (SCS) system offers the next generation of stimulation therapy, giving physicians the ability to treat multi-site and evolving painThe system builds on the company's proprietary therapy, BurstDR™ stimulation, that works by mimicking natural...
read article.
(1)
•••
edwardebreen15
X
View Profile
View Bullboard History
Post by
edwardebreen15
on Aug 18, 2022 1:13am
Stroke Management Market Size, Growth and Scope 2022-2027
According to IMARC Group’s latest report, titled “Stroke Management Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global stroke management market
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 11, 2022 9:00am
New Press Release - New Study Shows Abbott's Blood Test for Concussion Could Predict Outcomes from Brain Injury and Inform Treatment Interventions
The study concluded that elevated levels of two proteins help predict how a person will recover from a traumatic brain injury (TBI), providing important information to determine appropriate careResearchers used Abbott's i-STAT™ TBI Plasma test – the only FDA-cleared rapid test on a portable...
read article.
(1)
•••
edwardebreen15
X
View Profile
View Bullboard History
Post by
edwardebreen15
on Aug 10, 2022 5:59am
Meal Replacement Products Market Size and Share 2022-2027
According to IMARC Group’s latest report, titled “Meal Replacement Products Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” the global market reached a value
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
GameSquare Announces Formation of FaZe Media, Backed by $11M Investment
Xcyte Digital Corp. Releases "Xperience" Subscription Service
Drilling Approval Received for New Mexico Lithium Project